Enterprise Immune System
Vendor:
First CVE: Oct 23, 2019 · Active for 6 years
2
Total CVEs
More Total CVEs than 53% of tracked products
2.0
Avg CVEs / Year
Higher CVE frequency than 63% of tracked products
6.5
Avg CVSS
Higher Avg CVSS than 33% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Enterprise Immune System over time
Volume of CVEsAvg CVSS Base Score
First CVE
Oct 23, 2019
6 years ago
Most Recent CVE
Oct 23, 2019
2,470 days ago
CVE Severity & Scoring
Enterprise Immune System2 CVEs
100%
All CVEs353,173 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network2 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low2 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None0 (0.0%)
Unknown0 (0.0%)
Required2 (100.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None2 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2019-9596MEDIUM Darktrace Enterprise Immune System before 3.1 allows CSRF via the /whitelisteddomains endpoint. | Oct 23, 2019 | 6.5 | 18 | NO | NO |
CVE-2019-9597MEDIUM Darktrace Enterprise Immune System before 3.1 allows CSRF via the /config endpoint. | Oct 23, 2019 | 6.5 | 17 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (2 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (2 CVEs).
Media Mentions
Signals from CVEs in this product scope (2 CVEs).
Top CNAs Publishing CVEs For Enterprise Immune System
Top CWEs
Versions
No cataloged versions.